FIELD: chemistry.
SUBSTANCE: invention relates to the compounds of general formula I 
, where: X denotes (CR15R16)m-, where: m is 1, R15 and R16- hydrogen; R1 selected from the group consisting of 
A-B selected from the group consisting of N-C, C-N, N-N and C-C; D-E selected from the group consisting of O-C, S-C and O-N. The compounds can be used for the treatment of disorders modulated by opiotic receptors, for example, pain and gastroenteric disorder. The method of pharmaceutical composition production and application of the compounds are described.
EFFECT: production of the new compounds for the treatment of disorders modulated by opiotic receptors.
41 cl, 2 tbl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2815636C1 |
| OPTIONALLY CONDENSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES SUITABLE FOR TREATING INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2734261C2 |
| OPTIONALLY CONDENSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES SUITABLE FOR TREATING INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2719422C2 |
| HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2764243C2 |
| TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DESTROYERS | 2017 |
|
RU2797244C2 |
| ESTROGEN RECEPTOR PROTEOLYSIS MODULATORS AND RELATED USES THEREOF | 2018 |
|
RU2797808C2 |
| HYDROXAMATE DERIVATIVES SUITABLE AS DEACETYLASE INHIBITORS | 2001 |
|
RU2302408C2 |
| DIPYRAZOLES AS CENTRAL NERVOUS SYSTEM AGENTS | 2006 |
|
RU2401258C2 |
| IMIDAZOPYRIDINE COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2782743C2 |
| HETEROCYCLIC COMPOUNDS AND USES THEREOF | 2014 |
|
RU2680100C9 |
